18 June 2013
Keywords: fda, accepts, b-ms/imclone, erbitux, sbla, biotechnology, firm
Article | 10 November 2008
US biotechnology firm ImClone Systems and drug major and Bristol-Myers Squibb say that the Food and Drug Administration has accepted ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
10 November 2008
17 June 2013
© 2013 thepharmaletter.com